Loading…
Embecta Corp. entered a definitive agreement to acquire Owen Mumford Holdings Limited, a UK-based medical device and drug-delivery technology company, for up to £150 million (£100 million upfront plus up to £50 million in performance-based payments). The transaction is expected to close in Embecta's fiscal third quarter of 2026.
“Embecta Corp. today announced that it has entered into a definitive agreement to acquire Owen Mumford Holdings Limited, a privately held, UK‑based innovator and manufacturer of medical devices and drug‑delivery technologies, in a transaction valued at up to £150 million.”globenewswire.com
Summarized from public sources; check the original articles before acting on it.